|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
8
|
|
pubmed:dateCreated |
2004-4-15
|
|
pubmed:abstractText |
An open-label phase II study was conducted at two centers to establish the efficacy and safety of tositumomab and iodine I 131 tositumomab at first or second recurrence of indolent or transformed indolent B-cell lymphoma.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Apr
|
|
pubmed:issn |
0732-183X
|
|
pubmed:author |
pubmed-author:AmessJJ,
pubmed-author:BrittonK EKE,
pubmed-author:CarringtonB MBM,
pubmed-author:ClaytonJJ,
pubmed-author:DaviesA JAJ,
pubmed-author:DeakinD PDP,
pubmed-author:FoleyRR,
pubmed-author:HarrisMM,
pubmed-author:HowellSS,
pubmed-author:JanHH,
pubmed-author:KrollSS,
pubmed-author:LawranceJ AJA,
pubmed-author:ListerT ATA,
pubmed-author:MatherS JSJ,
pubmed-author:MicallefI NIN,
pubmed-author:NortonA JAJ,
pubmed-author:OwensS ESE,
pubmed-author:RadfordJ AJA,
pubmed-author:RohatinerA Z SAZ,
pubmed-author:VinnicombeSS
|
|
pubmed:issnType |
Print
|
|
pubmed:day |
15
|
|
pubmed:volume |
22
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
1469-79
|
|
pubmed:dateRevised |
2006-11-15
|
|
pubmed:meshHeading |
pubmed-meshheading:15084620-Adult,
pubmed-meshheading:15084620-Aged,
pubmed-meshheading:15084620-Antibodies, Monoclonal,
pubmed-meshheading:15084620-Antigens, CD20,
pubmed-meshheading:15084620-Antineoplastic Agents,
pubmed-meshheading:15084620-Humans,
pubmed-meshheading:15084620-Immunoconjugates,
pubmed-meshheading:15084620-Iodine Radioisotopes,
pubmed-meshheading:15084620-Lymphoma, B-Cell,
pubmed-meshheading:15084620-Middle Aged,
pubmed-meshheading:15084620-Neoplasm Recurrence, Local,
pubmed-meshheading:15084620-Radioimmunotherapy,
pubmed-meshheading:15084620-Survival Rate
|
|
pubmed:year |
2004
|
|
pubmed:articleTitle |
Tositumomab and iodine I 131 tositumomab for recurrent indolent and transformed B-cell non-Hodgkin's lymphoma.
|
|
pubmed:affiliation |
Cancer Research UK Medical Oncology Unit, Department of Medical Oncology, 45 Little Britain, St Bartholomew's Hospital, London EC1A 7BE, United Kingdom. Andrew.J.Davies@cancer.org.uk
|
|
pubmed:publicationType |
Journal Article,
Clinical Trial,
Research Support, Non-U.S. Gov't,
Multicenter Study,
Clinical Trial, Phase II
|
